Cargando…
Lobectomy offers improved survival outcomes relative to segmentectomy for >2 but ≤4 cm non–small cell lung cancer tumors
OBJECTIVE: The objective was to compare overall survival (OS) between lobectomy and segmentectomy for patients with non–small cell lung cancers (NSCLCs) > 2 but ≤4 cm. METHODS: The National Cancer Database was queried to identify treatment-naïve patients with NSCLC tumors >2 but ≤4 cm. Eligibl...
Autores principales: | Peng, Terrance, Wightman, Sean C., Ding, Li, Lieu, Dustin K., Atay, Scott M., David, Elizabeth A., Kim, Anthony W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390142/ https://www.ncbi.nlm.nih.gov/pubmed/36004221 http://dx.doi.org/10.1016/j.xjon.2022.03.002 |
Ejemplares similares
-
Thoracoscopic segmentectomy versus lobectomy: A propensity score–matched analysis
por: Sesma, Julio, et al.
Publicado: (2022) -
Surgical decision-making in advanced-stage non–small cell lung cancer is influenced by more than just guidelines
por: Peng, Terrance, et al.
Publicado: (2022) -
Adhering to guideline concordant care improves survival among the different subtypes of T3 N2 non–small cell lung cancer
por: Wang, Jennifer C., et al.
Publicado: (2022) -
Adjuvant chemotherapy, not radiotherapy, prolongs survival for node-negative non–small cell lung cancer with positive surgical margins
por: Ashrafi, Arman, et al.
Publicado: (2023) -
Delays to surgery and worse outcomes: The compounding effects of social determinants of health in non–small cell lung cancer
por: Ashrafi, Arman, et al.
Publicado: (2023)